Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (251-260 of 287) with videos related to

Pageof 29
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Plos One|July 30, 2013
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's diseaseChristine Breynaert, Tom Dresselaers, Clémentine Perrier, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensusWalter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|February 16, 2013
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's diseaseGert Van Assche, Karin A Herrmann, Edouard Louis, et al.
Plos One|December 30, 2014
Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitisJan Van der Goten, Wiebe Vanhove, Katleen Lemaire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Annals of Internal Medicine|December 8, 2015
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort StudyIsabelle Cleynen, Wouter Van Moerkercke, Thomas Billiet, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current managementAxel Dignass, James O Lindsay, Andreas Sturm, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
The New England Journal of Medicine|August 23, 2013
Vedolizumab as induction and maintenance therapy for ulcerative colitisBrian G Feagan, Paul Rutgeerts, Bruce E Sands, et al.
Pageof 29

Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Plos One|July 30, 2013
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's diseaseChristine Breynaert, Tom Dresselaers, Clémentine Perrier, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensusWalter Reinisch, Gert Van Assche, Ragnar Befrits, et al.
Journal of Crohn'S & Colitis|February 16, 2013
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's diseaseGert Van Assche, Karin A Herrmann, Edouard Louis, et al.
Plos One|December 30, 2014
Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitisJan Van der Goten, Wiebe Vanhove, Katleen Lemaire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Annals of Internal Medicine|December 8, 2015
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort StudyIsabelle Cleynen, Wouter Van Moerkercke, Thomas Billiet, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current managementAxel Dignass, James O Lindsay, Andreas Sturm, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
The New England Journal of Medicine|August 23, 2013
Vedolizumab as induction and maintenance therapy for ulcerative colitisBrian G Feagan, Paul Rutgeerts, Bruce E Sands, et al.
Pageof 29